Hormone replacement therapy and cardiovascular disease: does route of administration and formulation matter?
William
W
Foster
Gregory Y H
GY
Lip
D000279:Administration, Cutaneous; D000284:Administration, Oral; D015415:Biomarkers / Q000097:blood; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D015914:Estrogen Replacement Therapy / Q000379:methods*; D005260:Female; D006801:Humans
D015415:Biomarkers